887591-65-3 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(tert-Butoxycarbonyl)-3-ethyl-3-piperidinecarboxylic acid is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the creation of complex organic molecules with potential therapeutic applications.
Used in Agrochemical Development:
In the agrochemical industry, 1-(tert-Butoxycarbonyl)-3-ethyl-3-piperidinecarboxylic acid is utilized as a precursor for the development of new agrochemicals. Its versatility in synthesis enables the production of compounds with specific pesticidal or herbicidal properties.
Used in Organic Synthesis Research:
1-(tert-Butoxycarbonyl)-3-ethyl-3-piperidinecarboxylic acid is employed as a model compound in organic synthesis research. Its reactivity and the presence of the Boc protecting group make it an ideal candidate for studying new synthetic methods and reaction mechanisms.
Used in the Production of Complex Organic Molecules:
1-(tert-Butoxycarbonyl)-3-ethyl-3-piperidinecarboxylic acid is used as a building block for the assembly of complex organic molecules. Its structural features facilitate the synthesis of a wide range of organic compounds with diverse applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 887591-65-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,5,9 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 887591-65:
(8*8)+(7*8)+(6*7)+(5*5)+(4*9)+(3*1)+(2*6)+(1*5)=243
243 % 10 = 3
So 887591-65-3 is a valid CAS Registry Number.
887591-65-3Relevant academic research and scientific papers
N-BENZYL-3-PHENYL-3-HETEROCYCLYL-PROPIONAMIDE COMPOUNDS AS TACHYKININ AND/ OR SEROTONIN REUPTAKE INHIBITORS
-
Page 44, (2010/02/06)
The present invention relates to heterocyclic derivatives of formula (1) wherein R1 represents a 5 or 6 membered heteroaryl group, in which the 5-membered heteroaryl group contains at least one heteroatom selected from oxygen, sulphur or nitrogen and the 6-membered heteroaryl group contains from 1 to 3 nitrogen atoms, or R1 represents a 4,5 or 6 membered heterocyclic group, wherein saids 5 or 6 membered heteroaryl or the 4,5 or 6 membered heterocyclic group may optionally be substituted by one to three substituents, which may be the same or different, selected from (CH2)pR6, wherein p is zero or an integer from 1 to 4 and wherein R and R2- R6 are each as defined in the description and pharmaceutically acceptable salts and solvates thereof; process for their preparation and their use in the treatment of conditions mediated by tachykinins and/or by selective inhibition of serotonin reuptake transporter protein.
